Biyuan Wu

1.1k citations
10 papers · 913 indexed · 1 hit paper · h-index 9
Topics
Nanoplatforms for cancer theranostics (4 papers)Nanoparticle-Based Drug Delivery (3 papers)RNA Interference and Gene Delivery (3 papers)
Partner nations
ChinaUnited StatesMacao

In The Last Decade

Biyuan Wu

10 papers receiving 907 citations

Hit Papers

Mesoporous silica nanoparticles for drug and gene delivery20182026202020232018100200300400500

Peers

Biyuan Wu
Comparison fields: 5 of 97
  • Biomedical Engineering 345
  • Biomaterials 295
  • Materials Chemistry 261
  • Molecular Biology 251
  • Pharmaceutical Science 157
Replace Pratik Gurnani with:
Pratik Gurnani United Kingdom
Xiaoqian Feng China
Federica Foglietta Italy
Francesca Giuntini United Kingdom
Erik Jan Cornel China
Sharan Bobbala United States
Zhaoyou Chu China
Qiaoli Wu China
Italo Rodrigo Calori Brazil
Hongzhen Bai China
Biyuan Wu relative to Pratik Gurnani United Kingdom Pratik Gurnani's profile →
Citations per field
00.5×1.5×2.1×
Pratik Gurnani · 1×
Citations per year

Countries citing papers authored by Biyuan Wu

Since Specialization
Citations

This map shows the geographic impact of Biyuan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Biyuan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Biyuan Wu more than expected).

Fields of papers citing papers by Biyuan Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Biyuan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Biyuan Wu. The network helps show where Biyuan Wu may publish in the future.

Co-authorship network of co-authors of Biyuan Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Biyuan Wu. A scholar is included among the top collaborators of Biyuan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Biyuan Wu. Biyuan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 6
2 30
3 55
4 76
5 51
6 39
7 23
8 40
9
Mesoporous silica nanoparticles for drug and gene deliverybreakdown →
542
10 51

About Biyuan Wu

Biyuan Wu is a scholar working on Pharmaceutical Science, Microbiology and Biomaterials, having authored 10 papers that have together received 913 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (4 papers), Nanoparticle-Based Drug Delivery (3 papers) and RNA Interference and Gene Delivery (3 papers). The work is most often cited by research in Pharmaceutical Science (157 citations), Biomaterials (295 citations) and Microbiology (69 citations). Biyuan Wu has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Guilan Quan, Chuanbin Wu, Xin Pan, Yixian Zhou, Boyi Niu, Qiaoli Wu, Xiaoxu Zhang, Ying Huang, Jintao Fu and Chao Lü. Their work appears in journals such as ACS Applied Materials & Interfaces, Colloids and Surfaces B Biointerfaces and Pharmaceutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026